🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Some experts stated the demand for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.

Platform Reaction and Material Elimination

According to TikTok, the platform has taken down violative content and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

After minutes of entering one community, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, posts display black plastic parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly serious medical dangers”.